---
figid: PMC7551201__fonc-10-552283-g0006
figlink: pmc/articles/PMC7551201/figure/F6/
number: F6
caption: S100A4 increased motility of tumor cells. S100A4–RAGE interaction in tumor
  cells initiates activation of hypoxia, and MAPK/ERK signaling results in Wnt-β pathway
  activation and expression of β-catenin target genes, which promote elevated CRC
  cell motility. Calcimycin by suppressing the S100A4 promoter decreases S100A4 expression
  and other genes and inhibits Wnt-β pathway reverse S100A4 effect.
pmcid: PMC7551201
papertitle: Receptor for Advanced Glycation End Products Acts as a Fuel to Colorectal
  Cancer Development.
reftext: Fatemeh Azizian-Farsani, et al. Front Oncol. 2020;10:552283.
pmc_ranked_result_index: '9707'
pathway_score: 0.9293638
filename: fonc-10-552283-g0006.jpg
figtitle: S100A4 increased motility of tumor cells
year: '2020'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7551201__fonc-10-552283-g0006.html
  '@type': Dataset
  description: S100A4 increased motility of tumor cells. S100A4–RAGE interaction in
    tumor cells initiates activation of hypoxia, and MAPK/ERK signaling results in
    Wnt-β pathway activation and expression of β-catenin target genes, which promote
    elevated CRC cell motility. Calcimycin by suppressing the S100A4 promoter decreases
    S100A4 expression and other genes and inhibits Wnt-β pathway reverse S100A4 effect.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - S100A4
  - TLR4
  - AGER
  - MAPK3
  - MAPK1
  - MAPK14
  - MAPK8
  - MAPK11
  - MAPK13
  - MAPK12
  - MAPK9
  - MAPK10
  - CTNNB1
  - MYC
  - Calcimycin
  - Hypoxia
genes:
- word: S100A4
  symbol: S100A4
  source: hgnc_symbol
  hgnc_symbol: S100A4
  entrez: '6275'
- word: TLR4
  symbol: TLR4
  source: hgnc_symbol
  hgnc_symbol: TLR4
  entrez: '7099'
- word: RAGE
  symbol: RAGE
  source: hgnc_alias_symbol
  hgnc_symbol: AGER
  entrez: '177'
- word: MAPK/ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: MAPK/ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: MAPK/ERK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: MAPK/ERK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: MAPK/ERK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: MAPK/ERK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: MAPK/ERK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: MAPK/ERK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: MAPK/ERK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: MAPK/ERK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: MAPK/ERK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: Bcatenin
  symbol: BCATENIN
  source: bioentities_symbol
  hgnc_symbol: CTNNB1
  entrez: '1499'
- word: S100A4
  symbol: S100A4
  source: hgnc_symbol
  hgnc_symbol: S100A4
  entrez: '6275'
- word: c-myc,
  symbol: MYC
  source: hgnc_symbol
  hgnc_symbol: MYC
  entrez: '4609'
- word: S100A4
  symbol: S100A4
  source: hgnc_symbol
  hgnc_symbol: S100A4
  entrez: '6275'
chemicals:
- word: Calcimycin
  source: MESH
  identifier: D000001
diseases:
- word: Hypoxia
  source: MESH
  identifier: D000860
figid_alias: PMC7551201__F6
redirect_from: /figures/PMC7551201__F6
figtype: Figure
---
